Psychosocial Interventions for People with Amyotrophic Lateral Sclerosis and Motor Neuron Disease and Their Caregivers: a Scoping Review
Overview
Authors
Affiliations
Background: As amyotrophic lateral sclerosis/motor neuron disease (ALS/MND) is a fatal progressive neurodegenerative disorder, patients experience severe impairments, with patients and family caregivers facing emotional distress and exhaustion. Several psychosocial interventions are aimed at providing tailored support for ALS/MND patients and caregivers. The aim of this study was to conduct a scoping review and present a comprehensive overview of psychosocial interventions designed for individuals and families affected by ALS/MND, while also pinpointing research gaps.
Methods: This scoping review utilized Arksey and O'Malley's methodological framework to investigate psychosocial interventions designed for individuals with ALS/MND and their families. The study adhered to the PRISMA-ScR checklist for reporting.
Results: A total of 27 articles describing 25 interventions met the inclusion criteria. The predominant interventions observed in the research encompassed education-related strategies, closely followed by behavior therapy, counseling, social support interventions, and psychotherapy interventions. Across the majority of the studies, findings indicated promising feasibility and acceptability of these interventions. Notably, a significant proportion of quantitative investigations yielded one or more statistically significant effects, while qualitative studies consistently reported favorable outcomes, including enhancements in well-being and heightened awareness of individual circumstances.
Conclusions: Given the progressive and debilitating nature of this condition, coupled with the absence of a cure, the adoption of a psychosocial approach can prove beneficial for both ALS/MND patients and their families. However, high-quality RCTs with a large sample size are recommended to examine and confirm the effectiveness.
Okoh C, Mayall L, Makin S, Chen C, Zarotti N Brain Sci. 2025; 15(2).
PMID: 40002444 PMC: 11853713. DOI: 10.3390/brainsci15020112.
Segerstrom S, Kasarskis E Health Psychol Behav Med. 2024; 12(1):2396137.
PMID: 39239358 PMC: 11376292. DOI: 10.1080/21642850.2024.2396137.